This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akimitsu, N.
Right arrow Articles by Sekimizu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akimitsu, N.
Right arrow Articles by Sekimizu, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 1999, p. 3042-3043, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Increase in Resistance of Methicillin-Resistant Staphylococcus aureus to beta -Lactams Caused by Mutations Conferring Resistance to Benzalkonium Chloride, a Disinfectant Widely Used in Hospitals


    LETTER

Methicillin-resistant Staphylococcus aureus (MRSA) has been found worldwide and is one of the major nosocomial agents. When MRSA strains were first discovered in hospitals, resistance of MRSA to low concentrations of beta -lactams was evident, but increasing resistance to high concentrations of beta -lactams is now common. Most of the key elements responsible for methicillin resistance of MRSA have been well defined; however, mechanisms related to the acquisition of those genetic phenotypes in hospitals remain uncertain (4).

Appearance of MRSA resistant to benzalkonium chloride, a disinfectant widely used in hospitals, has been reported (1). To determine if the disinfectant might be related to increases in resistance to beta -lactams, we selected strains of MRSA which showed resistance to low concentrations of oxacillin (MIC, 2 to 32 µg/ml), isolated mutants resistant to benzalkonium, and then monitored the resistance to oxacillin. Approximately 2 × 108 cells of parent MRSA were seeded on a Luria-Bertani (LB) agar plate containing 5 µg of benzalkonium chloride per ml and incubated at 37°C for 3 days. The colonies which appeared were isolated as benzalkonium-resistant mutants. The MIC of benzalkonium for parent MRSA was 5 µg/ml, and the value for the isolated mutants increased to 10 µg/ml. Surprisingly, for 15 to 55% of benzalkonium chloride-resistant mutants from these parental strains the MICs of oxacillin were over eightfold higher than the MICs for the parent strains. MRSA strains highly resistant to oxacillin were also obtained with benzethonium chloride, another cationic detergent (data not shown).

Most benzalkonium chloride-resistant mutants with resistance to high concentrations of oxacillin formed small colonies on LB agar. Revertants which formed large colonies showed sensitivity to both benzalkonium chloride and oxacillin, as did the parent MRSA (data not shown). Thus, resistance to oxacillin and resistance to benzalkonium chloride are closely related and may be caused by a single mutation.

Isolation of S. aureus mutants resistant to benzalkonium chloride has been reported (1, 5-7), but a related increase in resistance to beta -lactam antibiotics has not been documented. We introduced into a wild type of S. aureus plasmid pTZ20 (6) containing the qacC gene, which is shown to cause resistance to disinfectants. The qacC gene alone increased resistance of S. aureus to benzalkonium chloride but not to beta -lactams (data not shown).

MRSA mutants resistant to benzalkonium chloride showed a higher resistance than parent strains to various beta -lactam antibiotics including cloxacillin, moxalactam, flomoxef, and cefmetazole (Table 1), as seen in the case of oxacillin. These mutants showed no remarkable increase in resistance to cefazolin and cephalothin (narrow-spectrum cephems), chloramphenicol (an inhibitor of protein synthesis) or ampicillin but did show resistance to ofloxacin, the lethal mechanisms of which differ from those of beta -lactams. It is possible that the mutation may affect the efficiency of uptake or may activate an efflux pump of drugs, in a nonspecific manner. Another possibility is that mutation of genes encoding elements regulating the expression of methicillin resistance, such as the femA gene (2), is responsible for the phenotype. Mutations responsible for the concomitant increase in resistance to benzalkonium chloride and beta -lactams will need to be identified.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Antibiotic resistance in MRSA and derived benzalkonium chloride-resistant mutants


    ACKNOWLEDGMENTS

We are grateful to Teruyo Ito, Keiichi Hiramatsu, Masahisa Noguchi, Hiroaki Nakayama, Matsuhisa Inoue, and Yasuyuki Ogata for helpful discussions and for materials.


    FOOTNOTES

* Phone: 81-3-5841-4820

Fax: 81-3-5684-2973

E-mail: sekimizu{at}mol.f.u-tokyo.ac.jp


    REFERENCES

1. Al-Masaudi, S. B., M. J. Day, and A. D. Russell. 1988. Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J. Appl. Bacteriol. 65:329-337[Medline].
2. Berger-Bachi, B., L. Barberis-Maino, A. Strassle, and F. H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219:263-269[Medline].
3. Hiramatsu, K., H. Kihara, and T. Yokota. 1992. Analysis of border line-resistant strains of methicillin resistant Staphylococcus aureus using polymerase chain reaction. Microbiol. Immunol. 36:445-453[Medline].
4. Hiramatsu, K. 1995. Molecular evolution of MRSA. Microbiol. Immunol. 39:531-543[Medline].
5. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608[Abstract/Free Full Text].
6. Sasatsu, M., Y. Shibata, S. Tamura, and M. Kono. 1990. Drug-resistant plasmids in multiply drug-resistant Staphylococcus aureus L20A. Microbios Lett. 43:105-112.
7. Sasatsu, M., Y. Shibata, N. Noguchi, and M. Kono. 1992. High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus. FEMS Microbiol. Lett. 93:109-114.
Nobuyoshi Akimitsu
Hiroshi Hamamoto
Ryu-ichi Inoue
Department of Molecular Microbiology
Graduate School of Pharmaceutical Sciences
Kyushu University
Fukuoka, Japan
Mikio Shoji
Akifumi Akamine
Department of Operative Dentistry and Endodontology
Faculty of Dentistry
Kyushu University
Fukuoka, Japan
Koh-ichi Takemori
Naotaka Hamasaki
Central Clinical Laboratory
Kyushu University Hospital
Fukuoka, Japan
Kazuhisa Sekimizu*
Laboratory of Developmental Biochemistry
Graduate School of Pharmaceutical Sciences
University of Tokyo
7-3-1, Hongo, Bunkyo-ku
Tokyo, Japan


Antimicrobial Agents and Chemotherapy, December 1999, p. 3042-3043, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Gant, V. A., Wren, M. W. D., Rollins, M. S. M., Jeanes, A., Hickok, S. S., Hall, T. J. (2007). Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms. J Antimicrob Chemother 60: 294-299 [Abstract] [Full Text]  
  • Kaito, C., Sekimizu, K. (2007). Colony Spreading in Staphylococcus aureus. J. Bacteriol. 189: 2553-2557 [Abstract] [Full Text]  
  • Edlind, M. P., Smith, W. L., Edlind, T. D. (2005). Effects of Cetylpyridinium Chloride Resistance and Treatment on Fluconazole Activity versus Candida albicans. Antimicrob. Agents Chemother. 49: 843-845 [Abstract] [Full Text]  
  • Hamamoto, H., Kurokawa, K., Kaito, C., Kamura, K., Manitra Razanajatovo, I., Kusuhara, H., Santa, T., Sekimizu, K. (2004). Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic Microorganisms. Antimicrob. Agents Chemother. 48: 774-779 [Abstract] [Full Text]  
  • Price, C. T. D., Singh, V. K., Jayaswal, R. K., Wilkinson, B. J., Gustafson, J. E. (2002). Pine Oil Cleaner-Resistant Staphylococcus aureus: Reduced Susceptibility to Vancomycin and Oxacillin and Involvement of SigB. Appl. Environ. Microbiol. 68: 5417-5421 [Abstract] [Full Text]  
  • Gilbert, P., McBain, A. J., Bloomfield, S. F. (2002). Biocide abuse and antimicrobial resistance: being clear about the issues. J Antimicrob Chemother 50: 137-139 [Full Text]  
  • Fraise, A. P. (2002). Biocide abuse and antimicrobial resistance--a cause for concern?. J Antimicrob Chemother 49: 11-12 [Full Text]  
  • Levy, S. B. (2002). Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 49: 25-30 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akimitsu, N.
Right arrow Articles by Sekimizu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akimitsu, N.
Right arrow Articles by Sekimizu, K.